These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36460471)

  • 21. Exploring the Economic Benefits of Modafinil for Post-Stroke Fatigue in Australia: A Cost-Effectiveness Evaluation.
    Bajorek B; Gao L; Lillicrap T; Bivard A; Garcia-Esperon C; Parsons M; Spratt N; Holliday E; Levi C
    J Stroke Cerebrovasc Dis; 2020 Nov; 29(11):105213. PubMed ID: 33066879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The cost-effectiveness of Australia's Active After-School Communities program.
    Moodie ML; Carter RC; Swinburn BA; Haby MM
    Obesity (Silver Spring); 2010 Aug; 18(8):1585-92. PubMed ID: 19893504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-effectiveness of gestational diabetes screening including prevention of type 2 diabetes: application of the GeDiForCE model in Australia.
    Beilby H; Yang F; Gannon B; McIntyre HD
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):8286-8293. PubMed ID: 34486452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An Economic Evaluation of Australia's Newborn Hearing Screening Program: A Within-Study Cost-Effectiveness Analysis.
    Sharma R; Gu Y; Sinha K; Ching TYC; Marnane V; Gold L; Wake M; Wang J; Parkinson B
    Ear Hear; 2022; 43(3):972-983. PubMed ID: 34772837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness of ovarian stimulation agents for IUI in couples with unexplained subfertility.
    van Eekelen R; Wang R; Danhof NA; Mol F; Mochtar M; Mol BW; van Wely M
    Hum Reprod; 2021 Apr; 36(5):1288-1295. PubMed ID: 33615360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-Effectiveness of Renal Denervation Therapy for Treatment-Resistant Hypertension: A Best Case Scenario.
    Chowdhury EK; Reid CM; Zomer E; Kelly DJ; Liew D
    Am J Hypertens; 2018 Sep; 31(10):1156-1163. PubMed ID: 30010694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-utility of angiotensin-converting enzyme inhibitor-based treatment compared with thiazide diuretic-based treatment for hypertension in elderly Australians considering diabetes as comorbidity.
    Chowdhury EK; Ademi Z; Moss JR; Wing LMH; Reid CM;
    Medicine (Baltimore); 2015 Mar; 94(9):e590. PubMed ID: 25738481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-effectiveness of rivaroxaban and aspirin compared to aspirin alone in patients with stable cardiovascular disease: An Australian perspective.
    Ademi Z; Zomer E; Tonkin A; Liew D
    Int J Cardiol; 2018 Nov; 270():54-59. PubMed ID: 30220379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An economic evaluation of vagus nerve stimulation as an adjunctive treatment to anti-seizure medications for the treatment of drug-resistant epilepsy in England.
    Raspin C; Shankar R; Barion F; Pollit V; Murphy J; Sawyer L; Danielson V
    J Med Econ; 2021; 24(1):1037-1051. PubMed ID: 34348576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Return on investment: a fuller assessment of the benefits and cost savings of the US publicly funded family planning program.
    Frost JJ; Sonfield A; Zolna MR; Finer LB
    Milbank Q; 2014 Dec; 92(4):696-749. PubMed ID: 25314928
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness of Installing Barriers at Bridge and Cliff Sites for Suicide Prevention in Australia.
    Bandara P; Pirkis J; Clapperton A; Shin S; Too LS; Reifels L; Onie S; Page A; Andriessen K; Krysinska K; Flego A; Schlichthorst M; Spittal MJ; Mihalopoulos C; Le LK
    JAMA Netw Open; 2022 Apr; 5(4):e226019. PubMed ID: 35380642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-effectiveness of embryo transfer strategies: a decision analytic model using long-term costs and consequences of singletons and multiples born as a consequence of IVF.
    van Heesch MM; van Asselt AD; Evers JL; van der Hoeven MA; Dumoulin JC; van Beijsterveldt CE; Bonsel GJ; Dykgraaf RH; van Goudoever JB; Koopman-Esseboom C; Nelen WL; Steiner K; Tamminga P; Tonch N; Torrance HL; Dirksen CD
    Hum Reprod; 2016 Nov; 31(11):2527-2540. PubMed ID: 27907897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness analysis of the multi-strategy WHO emergency care toolkit in regional referral hospitals in Uganda.
    Werner K; Risko N; Kalanzi J; Wallis LA; Reynolds TA
    PLoS One; 2022; 17(12):e0279074. PubMed ID: 36516176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancing the Detection and Care of Heterozygous Familial Hypercholesterolemia in Primary Care: Cost-Effectiveness and Return on Investment.
    Marquina C; Morton J; Brett T; Lloyd M; Radford J; Heal C; Hespe C; Gill G; Sullivan D; Zomer E; Li I; Pang J; Watts GF; Ademi Z
    Circ Genom Precis Med; 2023 Jun; 16(3):267-274. PubMed ID: 37042242
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Economic evaluation of a Decision Support Tool to guide intensity of mental health care in general practice: the Link-me pragmatic randomised controlled trial.
    Chatterton ML; Harris M; Burgess P; Fletcher S; Spittal MJ; Faller J; Palmer VJ; Chondros P; Bassilios B; Pirkis J; Gunn J; Mihalopoulos C
    BMC Prim Care; 2022 Sep; 23(1):236. PubMed ID: 36109694
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study.
    Wu O; Robertson L; Twaddle S; Lowe GD; Clark P; Greaves M; Walker ID; Langhorne P; Brenkel I; Regan L; Greer I
    Health Technol Assess; 2006 Apr; 10(11):1-110. PubMed ID: 16595080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Economic evaluation of a dietary intervention for adults with major depression (the "SMILES" trial).
    Chatterton ML; Mihalopoulos C; O'Neil A; Itsiopoulos C; Opie R; Castle D; Dash S; Brazionis L; Berk M; Jacka F
    BMC Public Health; 2018 May; 18(1):599. PubMed ID: 29783983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Public health impact and return on investment of Belgium's pediatric immunization program.
    Carrico J; Mellott CE; Talbird SE; Bento-Abreu A; Merckx B; Vandenhaute J; Benchabane D; Dauby N; Ethgen O; Lepage P; Luyten J; Raes M; Simoens S; Van Ranst M; Eiden A; Nyaku MK; Bencina G
    Front Public Health; 2023; 11():1032385. PubMed ID: 37427250
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.